A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1
Conditions: Narcolepsy Type 1 Interventions: Drug: ALKS 2680; Drug: Placebo Sponsors: Alkermes, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Mentalizating in Adults Suffering From Narcolepsy Type 1.
Conditions: Narcolepsy Type 1 Interventions: Behavioral: Mentalization Sponsors: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in the SYMPHONY Phase 3 Trial in Narcolepsy
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced that AXS-12... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 25, 2024 Category: Pharmaceuticals Source Type: clinical trials
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced topline... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 25, 2024 Category: Pharmaceuticals Source Type: clinical trials
Bacterial Translocation and Gut Microbiota in Type 1 Narcolepsy Patients Versus a Control Population
Conditions: Narcolepsy Type 1; Bacterial Translocation Interventions: Other: Blood sample; Other: Stool sample; Other: CSF sample Sponsors: Centre Hospitalier Universitaire de N īmes Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
Proteomics and Metabolomics of Body Fluid in Patients With Narcolepsy
Conditions: Narcolepsy Sponsors: Qilu Hospital of Shandong University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials
Improving Social Relationships for Adolescents With Central Disorders of Hypersomnolence
Conditions: Narcolepsy Type 1; Narcolepsy Type 2; Idiopathic Hypersomnia Interventions: Behavioral: Web-based psychoeducational resource Sponsors: Boston Children ' s Hospital; American Academy of Sleep Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
Transcutaneous Auricular Vagus Nerve Stimulation in Patients With Narcolepsy Type 1
Conditions: Narcolepsy Type 1; Fmri Interventions: Device: transcutaneous auricular vagus nerve stimulation Sponsors: Liu Yonghong Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)
Conditions: Narcolepsy Interventions: Drug: MK-6552; Drug: Placebo Sponsors: Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680
DUBLIN, Oct. 10, 2023, Alkermes plc today announced plans to present new data related to ALKS 2680, the company ' s novel, investigational orexin 2 receptor (OX2R) agonist in development for the treatment of narcolepsy, at World Sleep Congress, taking... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 10, 2023 Category: Pharmaceuticals Source Type: clinical trials
A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment
Conditions: Narcolepsy Type 1; Hypersomnia Intervention: Sponsors: Guy's and St Thomas' NHS Foundation Trust; University of Surrey Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials
